Embolic Protection Inc.

Venture capital firms, in pursuit of steady streams of early-stage opportunities, are establishing closer ties with the entrepreneurs and executives they feel can do it again. Tom Salemi Eager to secu

Analyzing the venture financings closed by 2004's new crop of biotech, diagnostics, and medical device start-ups reveals today's trends that may shape tomorrow's health care industry. The return of th

The next generation of protection companies knows they need more than just good clinical data to drive adoption. by Stephen Levin Nowhere in medicine have clinicians and product companies more heavily

Can this family-run company continue providing superior technology and responsiveness in the transition from OEM supplier to full-fledged interventional vascular products company? by Stephen Levin And